REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTransense Regulatory News (TRT)

Share Price Information for Transense (TRT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 124.00
Bid: 123.00
Ask: 125.00
Change: 2.00 (1.64%)
Spread: 2.00 (1.626%)
Open: 122.00
High: 124.00
Low: 122.00
Prev. Close: 122.00
TRT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares & TVR

20 Mar 2023 08:49

RNS Number : 5120T
Transense Technologies PLC
20 March 2023
 

The following announcement replaces the announcement issued today, 20 March 2023, at 07.00 under RNS number 4442T in its entirety, which was issued in error and duplicated the announcement issued on 13 March 2023 at 14.49 under RNS number 7923S. The full correct announcement is set out below.

 

Transense Technologies plc

("Transense" or the "Company")

 

Transaction in own shares

Change to Total Voting Rights

Transense Technologies plc (AIM: TRT), the developer of specialist sensor systems, announces that the Company has purchased 75,000 of its own ordinary shares of 10p each ("Ordinary Shares") at a price of 86.0 pence per share. These shares will be held in treasury for the time being to satisfy share option awards in the future.

Following this transaction, the total number of Ordinary Shares held as treasury shares by the Company is 729,027. The total number of Ordinary Shares in issue (including shares held as treasury shares) is 16,437,740. Therefore, the total number of voting rights in the Company is 15,708,713 which may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules. 

In accordance with Article 5(1)(b) of the UK version of Regulation (EU) No. 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, the information below contains information about the purchases made by Shard Capital Stockbrokers on behalf of the Company as part of the buyback programme.

 

 

Aggregate information:

Shares purchased:

Transense Technologies plc (ISIN CODE: GB00BDHDTH21)

Date of purchases:

17 March 2023

Investment firm

Shard Capital Stockbrokers

Venue

London Stock Exchange

Number of ordinary shares purchased

75,000

Volume-weighted average price, pence

86.0

Highest price paid (per ordinary share), pence

86.0

Lowest price paid (per ordinary share), pence

86.0

 

For further information please visit www.transense.com or contact:

Transense Technologies plc

Nigel Rogers (Executive Chairman)

Melvyn Segal (CFO)

Via Walbrook PR

Allenby Capital (Nominated Adviser and Broker)

Jeremy Porter / George Payne (Corporate Finance)

Tony Quirke (Sales and Corporate Broking)

Tel: +44 (0)20 3328 5656

Walbrook PR

Tom Cooper / Nick Rome

Tel: +44 (0)20 7933 8780

Transense@walbrookpr.com

Notes to Editors:

 

Transense develops and supplies wireless sensor technology and systems. The Company has three business areas:

Transense is a developer of specialist wireless sensor systems used to enable real-time data gathering and monitoring. Products include the patent protected Surface Acoustic Wave (SAW) sensor technology, used to improve equipment power, performance, reliability and efficiency; iTrack, Transense 's Tyre Pressure Monitoring System, licensed to Bridgestone Corporation, the world's largest tyre producer, under a ten-year deal in June 2020; and a range of intelligent tyre monitoring equipment under the Translogik brand. Target sectors include aerospace, electric motors & drives, industrial machinery and performance automotive. 

The Company 's strategy is to maximise shareholder value through the delivery of sustained revenue growth from all three principal technologies - SAW, iTrack and Translogik probes - through leveraging excellence in innovation, know-how in commercialising technologies, industry partnerships and exposure to global growth markets.

Transense is headquartered in Oxfordshire, UK, and was admitted to trading on AIM, a market operated by the London Stock Exchange (AIM: TRT), in 1999. www.transense.com .

For further information please contact transense@walbrookpr.com

 

Schedule of Purchases - Individual Transactions

 

Number of Shares

Price Per Share (pence)

Trading Venue

Date of Transaction

Time of transaction

75,000

86.0

London Stock Exchange

17 March 2023

16:35:00

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSJMMPTMTITMBJ
Date   Source Headline
31st Mar 20235:00 pmRNSTotal Voting Rights
27th Mar 20237:00 amRNSGrant of share options to Director and employees
20th Mar 20238:49 amRNSTransaction in Own Shares & TVR
20th Mar 20237:00 amRNSTransaction in Own Shares & TVR
13th Mar 20232:49 pmRNSTransaction in Own Shares & TVR
13th Mar 20237:00 amRNSDirectorate and Management Changes
22nd Feb 202310:52 amRNSDirector/PDMR Shareholding - acquisition of shares
22nd Feb 20237:00 amRNSInterim Results & Investor Presentation
7th Feb 20237:00 amRNSNotice of Results & Investor Presentation
30th Dec 20227:00 amRNSTotal Voting Rights
19th Dec 20226:22 pmRNSDirector/PDMR Shareholding
7th Dec 20222:10 pmRNSHolding(s) in Company
5th Dec 20227:00 amRNSTransaction in Own Shares & TVR
1st Dec 202212:03 pmRNSResult of AGM
1st Dec 20227:00 amRNSAGM Trading Update
30th Nov 20225:00 pmRNSTotal Voting Rights
14th Nov 20222:51 pmRNSTransaction in Own Shares & TVR
31st Oct 20225:00 pmRNSTotal Voting Rights
24th Oct 20227:00 amRNSPosting of Annual Report & Notice of AGM
17th Oct 20227:00 amRNSTransaction in Own Shares & TVR
4th Oct 20221:44 pmRNSHolding(s) in Company
27th Sep 202211:05 amRNSSecond Price Monitoring Extn
27th Sep 202211:00 amRNSPrice Monitoring Extension
27th Sep 20227:01 amRNSShare Repurchase Programme
27th Sep 20227:00 amRNSFinal Results & Investor Presentation
13th Sep 20227:00 amRNSMoU with Meggitt SA for SAW in aerospace sector
12th Sep 20227:00 amRNSNotice of Results, Investor Pres, AGM & Site visit
5th Jul 20227:00 amRNSYear End Trading Update
4th Jul 20227:00 amRNSSAW update - Appointment of Technical Director
21st Jun 202211:21 amRNSDirector/PDMR shareholding – acquisition of shares
31st May 20225:00 pmRNSTotal Voting Rights
27th May 20227:00 amRNSTransaction in own shares & TVR
26th May 20223:57 pmRNSHolding(s) in Company
24th May 20227:15 amRNSTransaction in own shares & TVR
19th May 20227:00 amRNSTransaction in Own Shares & TVR
17th May 20227:00 amRNSTRT wins place on TDAP & £135k Grant
16th May 20227:00 amRNSTransaction in Own Shares & TVR
11th May 20227:00 amRNSSAW Update
9th May 20227:00 amRNSTransaction in own shares & TVR
3rd May 20227:00 amRNSTransaction in own shares & TVR
26th Apr 20228:54 amRNSTransaction in Own Shares
19th Apr 20227:00 amRNSTransaction in Own Shares
2nd Mar 20225:15 pmRNSHolding(s) in Company
28th Feb 20227:00 amRNSDirector/PDMR - acquisition of shares
22nd Feb 20227:02 amRNSGrant of share options to employees
22nd Feb 20227:01 amRNSShare Repurchase Programme
22nd Feb 20227:00 amRNSInterim Results & Investor Presentation
31st Jan 20227:00 amRNSNotice of Results & Investor Presentation
23rd Dec 20212:51 pmRNSHolding(s) in Company
22nd Dec 20214:11 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.